Refining Management of CMV After Transplant: Exploiting Recent Advances to 
Alleviate Patient Burden
Program Information

A Hybrid Satellite Symposium

12:15 PM – 1:15 PM ET
Lunch will be provided

Philadelphia Marriott Downtown

Salon ABF, Level 5
1201 Market Street
Philadelphia, PA 19107

Also Available to Virtual Attendees via Online Simulcast

You must be registered for the American Transplant Congress 2024 to attend this symposium in-person.

This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.

Raymund R. Razonable, MD, FIDSA, FAST

Raymund R. Razonable, MD, FIDSA, FAST
Professor, Medicine
Program Director, Infectious Diseases Fellowship Program 
Vice Chair, Division of Infectious Diseases
Mayo Clinic
Rochester, MN
Fernanda P. Silveira , MD, MS, FIDSA, FAST

Fernanda P. Silveira, MD, MS, FIDSA, FAST
Professor, Medicine
Director, Clinical Operations, Transplant Infectious Diseases
University of Pittsburgh Medical Center
Pittsburgh, PA

Cytomegalovirus (CMV) is one of the most common infectious complications in solid organ transplant (SOT) recipients. During this symposium, the faculty will discuss best practices for prevention and treatment of CMV post-transplant and provide clinical pearls for managing difficult-to-treat CMV, including refractory or drug-resistant disease. You will learn first-hand from a patient with CMV about the burden and very personal aspects of this disease.

5 minutes

Raymund R. Razonable, MD, FIDSA, FAST
15 minutes

Raymund R. Razonable, MD, FIDSA, FAST
15 minutes

Fernanda P. Silveira, MD, MS, FIDSA, FAST
15 minutes

All Faculty and Patient
10 minutes

All Faculty

Transplant, infectious disease, internal medicine, nephrologists, pharmacy clinicians, and surgeons managing patients with CMV

Upon completion of this activity, participants should be better able to:

  • Assess the burden, risk factors, and impact of cytomegalovirus (CMV) on post-solid organ transplant (SOT) outcomes 
  • Utilize antiviral therapies for CMV prophylaxis and preemptive treatment in SOT recipients
  • Manage refractory or resistant CMV in SOT recipients, incorporating recent advances in antiviral therapy

Provided by RMEI Medical Education, LLC.

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Joint Accreditation Statement
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation

Physician Continuing Medical Education
RMEI Medical Education, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
RMEI Medical Education, LLC designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA-40008290-0000-24-002-L01-P)
Type of Activity: Knowledge
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Request for Credit
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be e-mailed to you within 3 weeks. Physicians who would like to claim American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points must provide ABIM ID and month/date of birth and score 75% or higher on the post-test. The post-test can be accessed through the QR code labeled “ABIM MOC POINTS” on the program flyer at your seat. MOC points will be submitted to ABIM profiles within 4 to 6 weeks of completion. If you have questions regarding the receipt of your e-mailed certificate, please contact RMEI via e-mail at

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at

There is no fee for this educational activity.

Facebook  Twitter  LinkedIn

Additional educational activities offered by RMEI Medical Education, LLC can be found
at or by calling toll-free (866) 770-RMEI.